JP2023091832A - Genus seriola cultured fish, and raising method of genus seriola cultured fish - Google Patents
Genus seriola cultured fish, and raising method of genus seriola cultured fish Download PDFInfo
- Publication number
- JP2023091832A JP2023091832A JP2021206642A JP2021206642A JP2023091832A JP 2023091832 A JP2023091832 A JP 2023091832A JP 2021206642 A JP2021206642 A JP 2021206642A JP 2021206642 A JP2021206642 A JP 2021206642A JP 2023091832 A JP2023091832 A JP 2023091832A
- Authority
- JP
- Japan
- Prior art keywords
- seriola
- content
- imidazole
- fish
- farmed fish
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000276699 Seriola Species 0.000 title claims abstract description 71
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 69
- 238000000034 method Methods 0.000 title claims description 21
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract description 144
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 68
- 229960003080 taurine Drugs 0.000 claims abstract description 33
- 150000001413 amino acids Chemical class 0.000 claims abstract description 32
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000011593 sulfur Substances 0.000 claims abstract description 9
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 9
- 235000013372 meat Nutrition 0.000 claims description 57
- 108010016626 Dipeptides Proteins 0.000 claims description 31
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 28
- 238000009395 breeding Methods 0.000 claims description 20
- 210000003205 muscle Anatomy 0.000 claims description 20
- -1 imidazole compound Chemical class 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 15
- 239000008280 blood Substances 0.000 claims description 15
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 14
- 108010085443 Anserine Proteins 0.000 claims description 13
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 claims description 13
- 241000210053 Potentilla elegans Species 0.000 claims description 13
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 claims description 13
- 229940000635 beta-alanine Drugs 0.000 claims description 7
- 230000037396 body weight Effects 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 abstract description 14
- 235000001014 amino acid Nutrition 0.000 description 30
- 229940024606 amino acid Drugs 0.000 description 30
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 27
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 18
- 150000002460 imidazoles Chemical class 0.000 description 16
- 239000006228 supernatant Substances 0.000 description 15
- 238000005119 centrifugation Methods 0.000 description 11
- 230000001488 breeding effect Effects 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000009360 aquaculture Methods 0.000 description 6
- 244000144974 aquaculture Species 0.000 description 6
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 235000019583 umami taste Nutrition 0.000 description 5
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 4
- 108010087806 Carnosine Proteins 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 4
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 4
- 229940044199 carnosine Drugs 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 229960004452 methionine Drugs 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 2
- BRMWTNUJHUMWMS-LURJTMIESA-N N(tele)-methyl-L-histidine Chemical compound CN1C=NC(C[C@H](N)C(O)=O)=C1 BRMWTNUJHUMWMS-LURJTMIESA-N 0.000 description 2
- 241000893636 Seriola lalandi Species 0.000 description 2
- 241000269796 Seriola quinqueradiata Species 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 241000276618 Perciformes Species 0.000 description 1
- 241000719215 Seriola carpenteri Species 0.000 description 1
- 241000132119 Seriola dumerili Species 0.000 description 1
- 241000347367 Seriola fasciata Species 0.000 description 1
- 241000719193 Seriola rivoliana Species 0.000 description 1
- 241000719210 Seriola zonata Species 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002907 effect on anemia Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000008722 morphological abnormality Effects 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Farming Of Fish And Shellfish (AREA)
Abstract
Description
本発明は、イミダゾール系化合物及びタウリンを高含有するブリ属養殖魚、及び当該ブリ属養殖魚を得るための育成方法に関する。 TECHNICAL FIELD The present invention relates to a cultured Seriola fish containing a high content of imidazole compounds and taurine, and a method for raising the cultured Seriola fish.
イミダゾール系化合物は、ヒスチジン関連化合物とも呼ばれ、遊離アミノ酸のヒスチジンや、ヒスチジンがメチル化されたπ-メチルヒスチジン及びτ-メチルヒスチジン、並びに、これらのヒスチジン系アミノ酸を含むジペプチドであるカルノシン及びアンセリン等がこれに包含される。イミダゾール系化合物の中でも、特にイミダゾールジペプチドは、緩衝作用、抗酸化力等を有し、脊椎動物、特に回遊性魚類の筋肉組織に多く含まれることが知られる(非特許文献1)。イミダゾールジペプチドは、ヒトが機能性食品として摂取すると、抗疲労効果、運動機能向上効果等が得られることが報告されている(非特許文献2)。 Imidazole-based compounds are also called histidine-related compounds, and include histidine as a free amino acid, π-methylhistidine and τ-methylhistidine in which histidine is methylated, and carnosine and anserine, which are dipeptides containing these histidine-based amino acids. is included in this. Among imidazole-based compounds, imidazole dipeptide in particular has a buffering effect, antioxidant power, etc., and is known to be abundantly contained in the muscle tissue of vertebrates, especially migratory fish (Non-Patent Document 1). It has been reported that when imidazole dipeptide is ingested by humans as a functional food, anti-fatigue effect, motor function improving effect, etc. can be obtained (Non-Patent Document 2).
タウリンは、2-アミノエタンスルホン酸、アミノエチルスルホン酸とも称される化合物であって、イカ、タコ、貝類、甲殻類及び魚類に多く含まれる成分である。生体内での浸透圧の調整や、生体膜の機能障害や形態異常が生じた際に回復・安定化させる作用を有することが知られる(非特許文献1)。高い抗酸化作用を有し、ヒトが機能性食品として摂取すると、血中コレステロール・中性脂肪の低下、肝臓等の機能向上、視力低下抑制、インスリン分泌促進、高血圧予防などの効果が得られることが知られる(非特許文献3)。 Taurine is a compound also called 2-aminoethanesulfonic acid and aminoethylsulfonic acid, and is a component abundantly contained in squid, octopus, shellfish, crustaceans and fish. It is known that it has the effect of regulating osmotic pressure in vivo and restoring and stabilizing biological membranes in the event of functional disorder or morphological abnormality (Non-Patent Document 1). It has a high antioxidant effect, and when humans ingest it as a functional food, effects such as lower blood cholesterol and triglycerides, improved liver function, suppression of visual acuity deterioration, promotion of insulin secretion, and prevention of hypertension can be obtained. is known (Non-Patent Document 3).
非特許文献4には、比較的高濃度のアンセリンを含む養殖ブリが開示されているが、普通肉に含まれるヒスチジンは約660mg/100gと低濃度であり、また血合肉に含まれるタウリン濃度も約200mg/100gと低濃度であることから、両成分の機能を十分に備える養殖魚であるとはいえない。
本発明は、抗酸化作用を有するイミダゾール系化合物及びタウリンを高含有するブリ属養殖魚を提供することを目的とする。また、本発明は、イミダゾール系化合物及びタウリンを高含有するブリ属養殖魚の育成方法を提供することを目的とする。 An object of the present invention is to provide a cultured fish of the genus Seriola that contains a high content of an imidazole compound and taurine having an antioxidant effect. Another object of the present invention is to provide a method for raising Seriola farmed fish containing high levels of imidazole compounds and taurine.
本発明は以下を提供するものである。
(1)可食部の筋肉組織のうち、普通肉のイミダゾール系化合物の含有量が820mg/100g以上であり、前記イミダゾール系化合物中のイミダゾールジペプチドの含有率が1.0重量%以上であり、可食部の筋肉組織のうち、血合肉のタウリンの含有量が250mg/100g以上である、ブリ属養殖魚。
(2)体重が1.0kg以上である、(1)に記載のブリ属養殖魚。
(3)普通肉のヒスチジンの含有量が800mg/100g以上である、(1)又は(2)に記載のブリ属養殖魚。
(4)前記イミダゾールジペプチドにアンセリンが含まれる、(1)~(3)のいずれかに記載のブリ属養殖魚。
(5)ブリ属養殖魚に、含硫アミノ酸を250mg/100g以上、イミダゾール系化合物を50mg/100g以上含む飼料を14日間以上連続して給餌することを含む、ブリ属養殖魚の育成方法。
(6)前記飼料が、β-アラニンを1.0mg/100g以上含む、(5)に記載の育成方法。
(7)ブリ属養殖魚を出荷直前に1~7日間絶食させることを含む、(5)又は(6)に記載の育成方法。
The present invention provides the following.
(1) Among the muscle tissue of the edible part, the content of the imidazole compound in normal meat is 820 mg / 100 g or more, and the imidazole dipeptide content in the imidazole compound is 1.0% by weight or more, A farmed fish of the genus Seriola, wherein the content of taurine in the blood meat is 250 mg/100 g or more in the muscle tissue of the edible part.
(2) The Seriola farmed fish according to (1), which weighs 1.0 kg or more.
(3) The Seriola farmed fish according to (1) or (2), wherein the content of histidine in normal meat is 800 mg/100 g or more.
(4) The Seriola farmed fish according to any one of (1) to (3), wherein the imidazole dipeptide contains anserine.
(5) A method for raising Seriola farmed fish, which comprises feeding Seriola farmed fish with feed containing 250 mg/100 g or more of a sulfur-containing amino acid and 50 mg/100 g or more of an imidazole compound continuously for 14 days or more.
(6) The breeding method according to (5), wherein the feed contains 1.0 mg/100 g or more of β-alanine.
(7) The breeding method according to (5) or (6), which includes fasting the Seriola farmed fish for 1 to 7 days immediately before shipment.
本発明によれば、抗酸化作用を有するイミダゾール系化合物及びタウリンを高含有するブリ属養殖魚を提供することが可能である。また、イミダゾール系化合物及びタウリンを高含有するブリ属養殖魚の育成方法を提供することが可能である。 INDUSTRIAL APPLICABILITY According to the present invention, it is possible to provide a cultured fish of the genus Seriola that contains a high content of an imidazole-based compound and taurine having an antioxidant action. In addition, it is possible to provide a method for raising Seriola farmed fish containing high levels of imidazole compounds and taurine.
<ブリ属養殖魚>
本発明のブリ属養殖魚は、可食部の筋肉組織のうち、普通肉のイミダゾール系化合物の含有量が820mg/100g以上であり、前記イミダゾール系化合物中のイミダゾールジペプチドの含有率が1.0重量%以上であり、可食部の筋肉組織のうち、血合肉のタウリンの含有量が250mg/100g以上である、ことを特徴とする。
<Seriola farmed fish>
In the Seriola farmed fish of the present invention, the imidazole compound content of normal meat in the muscle tissue of the edible part is 820 mg / 100 g or more, and the imidazole dipeptide content in the imidazole compound is 1.0. % by weight or more, and the content of taurine in the blood meat is 250 mg/100 g or more in the muscle tissue of the edible part.
本明細書において、「ブリ属」とは、スズキ目アジ科に分類される魚であり、学名Seriolaとして知られる魚である。ブリ属の魚としては、ブリ(Seriola quinqueradiata)、カンパチ(Seriola dumerili)、ヒラマサ(Seriola lalandi)、ヒレナガカンパチ(Seriola rivoliana)、Seriola carpenteri、Seriola fasciata、Seriola hippos、Seriola peruana、Seriola quinqueradiata、Seriola zonataなどが挙げられる。特にブリ又はカンパチが挙げられる。特に、ブリが挙げられる。 As used herein, “Seriola genus” refers to fish classified into the family Perciformes, and known as Seriola. Seriola quinqueradiata, Seriola dumerili, Seriola lalandi, Seriola rivoliana, Seriola carpenteri, Seriola fasciata, Seriola hipp os, Seriola peruana, Seriola quinqueradiata, Seriola zonata, etc. are mentioned. Yellowtail or amberjack are particularly mentioned. In particular, yellowtail is mentioned.
本明細書において、「養殖魚」とは、期間の長短に関わらず、出荷前に生簀等の飼育管理条件下で給餌、育成された魚を指す。本明細書において、「養殖魚」は天然種苗も人工孵化も含む。これに対して、「天然魚」は、海上で捕獲された後、出荷まで、飼育管理条件下での給餌、育成が行われていない魚を指す。ここでいう「飼育管理条件下」とは、人工的に各種条件を管理した環境下であることを示す。具体的な条件については、「ブリ属養殖魚の育成方法」の項に記載する。 As used herein, the term "farmed fish" refers to fish that have been fed and raised under breeding management conditions such as in cages before shipment, regardless of the length of the period. As used herein, "farmed fish" includes both natural seedlings and artificial hatching. In contrast, "wild fish" refers to fish that have not been fed and reared under breeding management conditions after being caught at sea until shipping. As used herein, the term "under rearing management conditions" indicates an environment in which various conditions are artificially controlled. Specific conditions are described in the section "Method for raising Seriola farmed fish".
本明細書において「可食部」とは、通常、ヒトが摂食する部分全てを指し、主に、筋肉組織であり、そのほか眼球周り、内臓などが挙げられる。ブリ属の可食部の多くは筋肉組織が占めており、筋肉組織は、通常の筋肉組織(本明細書では「普通肉」とも称する)と血合肉に分けられる。本明細書において「血合肉」とは、魚の背と腹の間に存在する赤色線維筋と呼ばれる、周囲の筋肉組織と比較して暗赤色を呈する部分を指す。筋肉組織は、通常、約75~85重量%が普通肉、約15~25重量%が血合肉で構成される。 As used herein, the term “edible part” generally refers to all parts that humans ingest, mainly muscle tissue, and also includes around the eyeballs, internal organs, and the like. Much of the edible part of the genus Seriola is occupied by muscle tissue, which is divided into normal muscle tissue (herein also referred to as "normal meat") and bloody meat. As used herein, the term "blood meat" refers to a portion called red fibrous muscle present between the back and belly of a fish, which is dark red in comparison with the surrounding muscle tissue. Muscle tissue is usually composed of about 75-85% by weight of normal meat and about 15-25% by weight of bloody meat.
本明細書において「イミダゾール系化合物」とは、イミダゾリン基を有する化合物全般を指すが、特にヒスチジン系アミノ酸全般を指す。ヒスチジン系アミノ酸としては、ヒスチジン、π-メチルヒスチジン、τ-メチルヒスチジン、及びイミダゾールジペプチド、並びにこれらの塩が挙げられる。本明細書において「イミダゾールジペプチド」とは、ヒスチジンとβ-アラニンとのジペプチドを指し、具体的にはカルノシン及びアンセリンを指す。また、「イミダゾールジペプチドの含有量」は具体的にはカルノシンとアンセリンの合計含有量を指す。本発明のブリ属養殖魚は、可食部の筋肉組織のうち、普通肉のイミダゾール系化合物の含有量が820mg/100g以上、特に、1000~1500mg/100gであり、かつ、イミダゾール系化合物中のイミダゾールジペプチドの含有量が1.0重量%以上、特に3.0~8.0重量%である。本発明のブリ属養殖魚は、普通肉にイミダゾールジペプチドとしてアンセリンが含まれることが好ましい。特に、普通肉におけるイミダゾールジペプチドに占めるアンセリンの量が、95重量%以上であることが好ましい。 As used herein, the term "imidazole-based compound" refers to all compounds having an imidazoline group, and particularly to all histidine-based amino acids. Histidine-based amino acids include histidine, π-methylhistidine, τ-methylhistidine, and imidazole dipeptides, and salts thereof. As used herein, "imidazole dipeptide" refers to a dipeptide of histidine and β-alanine, specifically carnosine and anserine. Moreover, the "content of imidazole dipeptide" specifically refers to the total content of carnosine and anserine. In the Seriola farmed fish of the present invention, the content of imidazole compounds in normal meat is 820 mg / 100 g or more, particularly 1000 to 1500 mg / 100 g, in the muscle tissue of the edible part, and the imidazole compound in the The content of imidazole dipeptide is 1.0% by weight or more, especially 3.0 to 8.0% by weight. The Seriola farmed fish of the present invention preferably contains anserine as imidazole dipeptide in normal meat. In particular, the content of anserine in imidazole dipeptide in normal meat is preferably 95% by weight or more.
本明細書において、イミダゾール系化合物(イミダゾールジペプチドを含む)の含有量は、以下の方法で測定した量を指す。適切な量の試料を秤量し、0.02M塩酸を添加して破砕した後、9倍容量となるよう0.02M塩酸を添加する。試料を十分に攪拌した後、遠心分離により上清液を分離する。上清液に対して等容量の3%スルホサリチル酸水溶液を加え、再度遠心分離を行い、上清部を回収して除タンパク処理を行う。さらにn-ヘキサンを加えて攪拌後、遠心分離を行い、下層部を回収して脱脂処理を行う。この溶液又は必要に応じて10倍希釈した溶液をメンブレンろ過したろ液を、アミノ酸分析計(例えば、日立製作所製LA8080)に供して、イミダゾール系化合物の種類及び含有量を測定する。 As used herein, the content of imidazole compounds (including imidazole dipeptide) refers to the amount measured by the following method. An appropriate amount of sample is weighed, 0.02M hydrochloric acid is added and crushed, and then 0.02M hydrochloric acid is added to make the volume 9 times. After thoroughly stirring the sample, the supernatant is separated by centrifugation. An equal volume of 3% sulfosalicylic acid aqueous solution is added to the supernatant, centrifugation is performed again, and the supernatant is recovered and subjected to protein removal treatment. Further, after adding n-hexane and stirring, centrifugal separation is performed, and the lower layer is collected and degreased. This solution or a solution diluted 10-fold as necessary is filtered through a membrane, and the filtrate is subjected to an amino acid analyzer (for example, LA8080 manufactured by Hitachi, Ltd.) to measure the type and content of imidazole compounds.
本発明のブリ属養殖魚において、普通肉に含まれるイミダゾール系化合物のうち、ヒスチジンの含有量が800mg/100g以上、特に900~1300mg/100gであり、かつイミダゾール系化合物中のイミダゾールジペプチドの含有量が1.0重量%以上であることが好ましい。ヒスチジンは必須アミノ酸の1つであり、生体内のタンパク質合成に必要な重要な成分である。ヒスチジンはアレルギー反応に関与するヒスタミンに変換されることから、過剰量の摂取は望ましくないが、一方で、血管拡張作用による血圧低下や虚血性脳障害の予防、透析による貧血の治療効果や、食欲抑制による脂肪燃焼促進作用が知られている。また、ヒスチジンは、神経機能への関与や、赤血球の形成に必要であることから貧血への効果、紫外線による皮膚への刺激軽減作用や抗酸化作用を有することが知られており、適量で摂取する限りでは有用な成分である。 In the Seriola farmed fish of the present invention, among the imidazole compounds contained in normal meat, the histidine content is 800 mg/100 g or more, particularly 900 to 1300 mg/100 g, and the imidazole dipeptide content in the imidazole compounds. is preferably 1.0% by weight or more. Histidine is one of the essential amino acids and an important component required for protein synthesis in vivo. Since histidine is converted to histamine, which is involved in allergic reactions, excessive intake is not desirable. Suppression is known to promote fat burning. In addition, histidine is known to have an effect on anemia because it is involved in nerve function and necessary for the formation of red blood cells. It is a useful ingredient as long as it does.
本明細書において、ヒスチジンの含有量は、以下の方法で測定した量を指す。適切な量の試料を秤量し、0.02M塩酸を添加して破砕した後、9倍容量となるよう0.02M塩酸を添加する。試料を十分に攪拌した後、遠心分離により上清液を分離する。上清液に対して等容量の3%スルホサリチル酸水溶液を加え、再度遠心分離を行い、上清部を回収して除タンパク処理を行う。さらにn-ヘキサンを加えて攪拌後、遠心分離を行い、下層部を回収して脱脂処理を行う。この溶液又は必要に応じて10倍希釈した溶液をメンブレンろ過したろ液を、アミノ酸分析計(例えば、日立製作所製LA8080)に供して、ヒスチジンの含有量を測定する。 As used herein, the content of histidine refers to the amount measured by the following method. An appropriate amount of sample is weighed, 0.02M hydrochloric acid is added and crushed, and then 0.02M hydrochloric acid is added to make the volume 9 times. After thoroughly stirring the sample, the supernatant is separated by centrifugation. An equal volume of 3% sulfosalicylic acid aqueous solution is added to the supernatant, centrifugation is performed again, and the supernatant is recovered and subjected to protein removal treatment. Further, after adding n-hexane and stirring, centrifugal separation is performed, and the lower layer is collected and degreased. The filtrate obtained by filtering this solution or a solution diluted 10-fold as necessary through a membrane is subjected to an amino acid analyzer (for example, LA8080 manufactured by Hitachi, Ltd.) to measure the histidine content.
本明細書において「タウリン」とは、2-アミノエタンスルホン酸、アミノエチルスルホン酸とも称される化合物を指す。本発明のブリ属養殖魚は、可食部の筋肉組織のうち、血合肉のタウリンの含有量が250mg/100g以上、特に、350~1200mg/100gである。 As used herein, "taurine" refers to a compound also called 2-aminoethanesulfonic acid, aminoethylsulfonic acid. In the Seriola farmed fish of the present invention, the taurine content of the blood meat in the muscle tissue of the edible part is 250 mg/100 g or more, particularly 350 to 1200 mg/100 g.
本明細書においてタウリンの含有量は、以下の方法で測定した量を指す。適切な量の試料を秤量し、0.02M塩酸を添加して破砕した後、9倍容量となるよう0.02M塩酸を添加する。試料を十分に攪拌した後、遠心分離により上清液を分離する。上清液に対して等容量の3%スルホサリチル酸水溶液を加え、再度遠心分離を行い、上清部を回収して除タンパク処理を行う。さらにn-ヘキサンを加えて攪拌後、遠心分離を行い、下層部を回収して脱脂処理を行う。この溶液又は必要に応じて10倍希釈した溶液をメンブレンろ過したろ液を、アミノ酸分析計(例えば、日立製作所製LA8080)に供して、タウリンの含有量を測定する。 As used herein, the content of taurine refers to the amount measured by the following method. An appropriate amount of sample is weighed, 0.02M hydrochloric acid is added and crushed, and then 0.02M hydrochloric acid is added to make the volume 9 times. After thoroughly stirring the sample, the supernatant is separated by centrifugation. An equal volume of 3% sulfosalicylic acid aqueous solution is added to the supernatant, centrifugation is performed again, and the supernatant is recovered and subjected to protein removal treatment. Further, after adding n-hexane and stirring, centrifugal separation is performed, and the lower layer is collected and degreased. This solution or a solution diluted 10-fold as necessary is filtered through a membrane, and the filtrate is subjected to an amino acid analyzer (for example, LA8080 manufactured by Hitachi Ltd.) to measure the taurine content.
本発明のブリ属養殖魚は、一定以上成長した魚であることが好ましい。具体的には、体重が1.0kg以上、特に2.0kg以上であることが好ましい。すなわち、本発明のブリ属養殖魚の好適例は、モジャコ等と称される稚魚を含まない。 The Seriola farmed fish of the present invention is preferably a fish that has grown to a certain level or more. Specifically, it is preferable that the body weight is 1.0 kg or more, particularly 2.0 kg or more. That is, preferred examples of the Seriola aquaculture fish of the present invention do not include juvenile fish called mojako.
<ブリ属養殖魚の育成方法>
本発明のブリ属養殖魚の育成方法は、ブリ属養殖魚に、含硫アミノ酸を250mg/100g以上、イミダゾール系化合物を50mg/100g以上含む飼料を14日間以上連続して給餌することを含む、ことを特徴とする。本明細書において、「含硫アミノ酸」とは、タウリン、メチオニン、システイン及びホモシステイン、好適にはタウリン及びメチオニンを指す。
<Method of raising Seriola farmed fish>
The method for raising Seriola farmed fish of the present invention comprises feeding Seriola farmed fish with feed containing 250 mg/100 g or more of sulfur-containing amino acids and 50 mg/100 g or more of imidazole compounds for 14 days or more continuously. characterized by As used herein, "sulphur-containing amino acid" refers to taurine, methionine, cysteine and homocysteine, preferably taurine and methionine.
1.養殖対象のブリ属
本発明の育成方法で養殖されるブリ属は、人工孵化由来であっても、天然種苗由来であってもよい。養殖開始時期のブリ属の齢数はその養殖期間によって異なるが、出荷時までにブリ属の魚体重が1kg以上となるよう育成することが好ましい。
1. Seriola to be cultured The Seriola to be cultured by the method of the present invention may be derived from artificial hatching or natural seedlings. The number of ages of Seriola at the start of aquaculture varies depending on the aquaculture period, but it is preferable to grow Seriola so that the weight of Seriola will reach 1 kg or more by the time of shipment.
2.飼育管理条件下での養殖
上記の養殖対象となるブリ属を、専用の生簀や水槽に移して、飼育管理条件下で養殖する。養殖時の条件として、給餌、水温、魚の密度などを調整し、管理することを要する。
2. Aquaculture under breeding management conditions The above-mentioned Seriola genus to be cultivated is transferred to a dedicated fish cage or water tank and cultivated under breeding management conditions. As conditions during aquaculture, it is necessary to adjust and manage feeding, water temperature, fish density, and the like.
(1)養殖期間と給餌条件
本発明の育成方法において、養殖期間は、出荷前の14日間以上、好ましくは30日間以上、より好ましくは60日間以上、特に好ましくは90日間以上とする。そのうち、出荷直前の1~7日間(24~168時間)、好ましくは1~3日間(24~72時間)、より好ましくは1~2日間(24~48時間)給餌を中止し、絶食期間を設けることが好ましい。本発明者らは、前記絶食期間を設けることで、ブリ属養殖魚の可食部に含まれるイミダゾールジペプチド及びタウリンが増加し、ヒスチジンが減少することを確認した。また、絶食期間を設けることで、ブリ属養殖魚の可食部に含まれる旨味アミノ酸の含有量が増加し、苦味アミノ酸の含有量が減少することも確認した。絶食期間を経たブリ属養殖魚は、直ちに出荷されることが好ましい。
(1) Culture Period and Feeding Conditions In the breeding method of the present invention, the culture period is 14 days or more, preferably 30 days or more, more preferably 60 days or more, and particularly preferably 90 days or more before shipment. Among them, 1 to 7 days (24 to 168 hours) immediately before shipping, preferably 1 to 3 days (24 to 72 hours), more preferably 1 to 2 days (24 to 48 hours) Stop feeding, fasting period It is preferable to provide The present inventors confirmed that imidazole dipeptide and taurine contained in the edible portion of Seriola farmed fish increased and histidine decreased by providing the fasting period. It was also confirmed that the edible portion of Seriola farmed fish increased the content of umami amino acids and decreased the content of bitter amino acids by providing a fasting period. Seriola farmed fish that have undergone a fasting period are preferably shipped immediately.
絶食期間前の養殖期間において、給餌は、少なくとも1日1回、生簀内に散布して行うことが好ましい。絶食期間直前(絶食期間を設けない場合は出荷直前)の14日間以上、好ましくは30~90日間、含硫アミノ酸及びイミダゾール系化合物を所定量以上含む飼料を与える。養殖期間に給餌する飼料の含硫アミノ酸の含有量は、250mg/100g以上、好ましくは300mg/100g以上とする。イミダゾール系化合物の含有量は、50mg/100g以上、好ましくは70mg/100g以上とする。前記飼料には、さらに、β-アラニンが、1.0mg/100g以上、特に1.2mg/100g以上含まれることが好ましい。 During the aquaculture period before the fasting period, feeding is preferably carried out by spraying in the cage at least once a day. For 14 days or more, preferably 30 to 90 days, immediately before the fasting period (or immediately before shipment if no fasting period is provided), feed containing a predetermined amount or more of the sulfur-containing amino acid and the imidazole compound is given. The content of sulfur-containing amino acids in the feed fed during the cultivation period should be 250 mg/100 g or more, preferably 300 mg/100 g or more. The content of the imidazole compound is 50 mg/100 g or more, preferably 70 mg/100 g or more. Preferably, the feed further contains β-alanine in an amount of 1.0 mg/100 g or more, particularly 1.2 mg/100 g or more.
飼料は、含硫アミノ酸及びイミダゾール系化合物を所定量以上含むものであれば特に限定されず、ペレット等の配合飼料であってもよく、また、サバ、イワシ、アジ等の生餌を粉砕してモイストペレット用配合飼料と混合したものとしてもよい。配合飼料の原料は特に限定されないが、通常は、動物質性飼料、穀類、植物性油かす類、油脂、各種ビタミン、ミネラル類等を含む。 The feed is not particularly limited as long as it contains a predetermined amount or more of sulfur-containing amino acids and imidazole compounds. It may be mixed with a mixed feed for moist pellets. The raw materials of the mixed feed are not particularly limited, but usually include animal feed, cereals, vegetable oil cakes, oils and fats, various vitamins, minerals and the like.
(2)水温
ブリを養殖するための生簀や水槽内の水温は、15~28℃、特に、18~27℃、さらに20~25℃とすることが好ましい。ブリの生簀は、通常海上に設置されるため、設置後の生簀内の水温を人為的に調節することは困難であるが、例えば、生簀の設置箇所を適切に選択することで、所望の温度条件下での養殖を行うことが可能である。
(2) Water temperature The water temperature in fish cages and water tanks for cultivating yellowtail is preferably 15 to 28°C, particularly 18 to 27°C, more preferably 20 to 25°C. Since yellowtail fish cages are usually installed on the sea, it is difficult to artificially adjust the water temperature in the fish cage after installation. It is possible to carry out aquaculture under conditions.
(3)飼育密度
生簀や水槽内のブリの飼育密度は、3~20kg/m3、特に、7~16kg/m3とすることが好ましい。生簀や水槽の大きさは、ブリの各個体が他の個体と接触することなく遊泳可能であれば、特に限定されないが、例えば、縦及び横が8~60m、深さ8~25m程度の大きさとすることができる。
(3) Breeding Density The breeding density of yellowtails in a cage or water tank is preferably 3 to 20 kg/m 3 , particularly 7 to 16 kg/m 3 . The size of the fish preserve or water tank is not particularly limited as long as each yellowtail individual can swim without contacting other individuals. It can be said.
本発明の方法は、上記の飼育管理条件及び給餌条件下でブリ属を養殖することにより、抗酸化作用を有するイミダゾール系化合物及びタウリンを高濃度で含有するブリ属養殖魚を得ることを可能とする。 The method of the present invention makes it possible to obtain Seriola farmed fish containing high concentrations of imidazole compounds and taurine having antioxidant properties by culturing Seriola under the above breeding management conditions and feeding conditions. do.
以下、実施例において本発明をさらに詳細に説明するが、以下の実施例は本発明を限定するものではない。 EXAMPLES The present invention will be described in more detail in the following examples, but the following examples are not intended to limit the present invention.
<実施例1.ブリの飼育試験>
養殖場A・Bにおいて、ブリの飼育実験を行った。養殖場A・Bにおける飼育管理条件を表1に示す。
<Example 1. Breeding test of yellowtail>
A yellowtail breeding experiment was conducted at farms A and B. Table 1 shows the breeding management conditions at farms A and B.
<実施例2.飼料の成分分析>
養殖場A・Bで使用した配合飼料について、含まれるイミダゾール系化合物、ヒスチジン、イミダゾールジペプチド、アンセリン、タウリン、メチオニン及びβアラニンの量を測定した。
<Example 2. Component Analysis of Feed>
The amounts of imidazole compound, histidine, imidazole dipeptide, anserine, taurine, methionine and β-alanine contained in the compound feed used at farms A and B were measured.
各種成分の測定は、以下の方法で行った。所定量の配合飼料に0.02M塩酸を加えて破砕し、抽出処理を行った。これを遠心分離(5000rpm、15分、4℃)した後、上清に3%スルホサリチル酸水溶液を加え、さらに遠心分離(5000rpm、15分、4℃)を行ってタンパク質を除去した。上清にn-ヘキサンを加えて脂質成分を除去した後、アミノ酸分析装置(日立製作所製LA8080)で各種成分の含有量を分析した。 Various components were measured by the following methods. 0.02M hydrochloric acid was added to a predetermined amount of compound feed, crushed, and extracted. After centrifugation (5000 rpm, 15 minutes, 4° C.), a 3% sulfosalicylic acid aqueous solution was added to the supernatant, followed by centrifugation (5000 rpm, 15 minutes, 4° C.) to remove proteins. After removing lipid components by adding n-hexane to the supernatant, the contents of various components were analyzed with an amino acid analyzer (LA8080, manufactured by Hitachi, Ltd.).
上記の方法で測定した配合飼料中のイミダゾール系化合物、ヒスチジン、イミダゾールジペプチド、アンセリン及びタウリンの含有量を表2に示す。 Table 2 shows the contents of imidazole compounds, histidine, imidazole dipeptide, anserine and taurine in the compound feed measured by the above method.
<実施例3.養殖ブリの絶食期間と筋肉組織の各種アミノ酸含有量>
養殖場Bで飼育された後、0、1、3、7日間の絶食期間を経た養殖ブリについて、可食部の普通肉と血合肉を切り出し、普通肉中のヒスチジン、イミダゾールジペプチド(アンセリン、カルノシン)の含有量、並びに血合肉中のタウリンの含有量を測定した。また、普通肉における旨味アミノ酸(アスパラギン酸、グルタミン酸、アスパラギン)及び苦味アミノ酸(アルギニン、ヒスチジン、バリン、イソロイシン、メチオニン、フェニルアラニン)の含有量を測定した。
<Example 3. Fasting period of cultured yellowtail and various amino acid contents in muscle tissue>
After being reared at farm B, the farmed yellowtail that has undergone a fasting period of 0, 1, 3, and 7 days was cut out from the edible portion of normal meat and blood meat, and the histidine and imidazole dipeptides (anserine, carnosine) in the normal meat were analyzed. ) and the taurine content in the blood meat were measured. In addition, the contents of umami amino acids (aspartic acid, glutamic acid, asparagine) and bitter amino acids (arginine, histidine, valine, isoleucine, methionine, phenylalanine) in normal meat were measured.
各種アミノ酸、イミダゾールジペプチド及びタウリンの含有量の測定は以下の方法で実施した。水揚げした魚体の血抜き処理を行った後、塩水氷水下で冷却した。その後、冷蔵庫内で普通肉と血合肉を採取した。適切な量の採取した肉を秤量し、0.02M塩酸を添加して破砕した後、9倍容量となるよう0.02M塩酸を添加した。試料を十分に攪拌した後、遠心分離(3000rpm、10分、4℃)により上清液を分離した。上清液に対して等容量の3%スルホサリチル酸水溶液を加え、再度遠心分離(10000rpm、10分、4℃)を行い、上清部を回収して除タンパク処理を行った。さらに上清液に対して2/3倍量のn-ヘキサンを加えて攪拌後、遠心分離(10000rpm、10分、4℃)を行い、下層部を回収して脱脂処理を行った。この溶液又は必要に応じて10倍希釈した溶液をメンブレンろ過(0.45μm)したろ液を、アミノ酸分析計(日立製作所製LA8080)に供して、各種アミノ酸の含有量を分析した。測定は、各条件につき1尾の養殖ブリについて行った。 Contents of various amino acids, imidazole dipeptide and taurine were measured by the following methods. After blood was removed from the landed fish, it was cooled in salt water and ice water. After that, normal meat and bloody meat were collected in the refrigerator. An appropriate amount of the collected meat was weighed, 0.02M hydrochloric acid was added and crushed, and then 0.02M hydrochloric acid was added to 9 times the volume. After thoroughly stirring the sample, the supernatant was separated by centrifugation (3000 rpm, 10 minutes, 4°C). An equal volume of 3% sulfosalicylic acid aqueous solution was added to the supernatant, centrifugation was performed again (10000 rpm, 10 minutes, 4° C.), and the supernatant was recovered and subjected to protein removal treatment. Further, 2/3 times the amount of n-hexane was added to the supernatant, and after stirring, centrifugation (10000 rpm, 10 minutes, 4° C.) was performed, and the lower layer was collected and degreased. This solution or a solution diluted 10-fold as necessary was filtered through a membrane (0.45 μm), and the filtrate was subjected to an amino acid analyzer (LA8080 manufactured by Hitachi, Ltd.) to analyze the contents of various amino acids. The measurement was performed on one cultured yellowtail for each condition.
図1及び2は、それぞれ普通肉中のヒスチジン及びイミダゾールジペプチドの含有量と絶食期間との関係を示すグラフである。図3は、血合肉中のタウリンの含有量と絶食期間との関係を示すグラフである。図4は、普通肉における旨味アミノ酸の含有量と絶食期間との関係を示すグラフである。図5は、普通肉における苦味アミノ酸の含有量と絶食期間との関係を示すグラフである。いずれのグラフも、絶食期間0日の普通肉/血合肉における含有量を1.0として、各試料の含有量測定値を算出した値を示す。
Figures 1 and 2 are graphs showing the relationship between the content of histidine and imidazole dipeptide in normal meat and the fasting period, respectively. FIG. 3 is a graph showing the relationship between the taurine content in blooded meat and the fasting period. FIG. 4 is a graph showing the relationship between the content of umami amino acids in normal meat and the fasting period. FIG. 5 is a graph showing the relationship between the content of bitter amino acids in normal meat and the fasting period. Both graphs show values obtained by calculating the measured content of each sample, with the content in normal meat/blood meat on
絶食期間を設けることで普通肉のヒスチジン含有量がわずかに減少すること、絶食期間3日目頃までは、イミダゾールジペプチドが増加することが確認された(図1、図2)。血合肉に含まれるタウリンの含有量は、絶食期間を設けることで増加することが確認された(図3)。また、絶食期間を設けることで、普通肉の旨味アミノ酸の含有量が増加し、苦味アミノ酸の含有量がわずかに減少することが確認された(図4、図5)。
It was confirmed that the histidine content of normal meat decreased slightly by providing a fasting period, and that imidazole dipeptide increased until about
<実施例4.既知の養殖ブリとの比較>
養殖場A・Bで絶食期間なしで飼育した養殖ブリについて、可食部の普通肉と血合肉を切り出し、普通肉中のイミダゾール系化合物、ヒスチジン及びイミダゾールジペプチドの含有量、並びに血合肉中のタウリンの含有量を測定した。各種測定は、実施例3と同様の方法で行った。各条件における養殖ブリに含まれる成分を表3に示す。養殖場A・Bで飼育された養殖ブリにおいて、例えば、非特許文献4に記載の養殖ブリ(比較例)と比較して、イミダゾールジペプチドの含有量が同等であり、かつイミダゾール系化合物とタウリン含有量が有意に高くなることが示された。
<Example 4. Comparison with known farmed yellowtail>
From farmed yellowtails raised without a fasting period at farms A and B, the normal meat and bloody meat of the edible part were cut out, and the contents of imidazole compounds, histidine and imidazole dipeptide in the normal meat, and taurine in the bloody meat were measured. was measured. Various measurements were performed in the same manner as in Example 3. Table 3 shows the ingredients contained in the cultured yellowtail under each condition. The farmed yellowtail raised at farms A and B has the same imidazole dipeptide content and contains an imidazole compound and taurine as compared with, for example, the farmed yellowtail (comparative example) described in
本発明は以下を提供するものである。
(1) ブリ属養殖魚の育成方法であって、
ブリ属養殖魚に、含硫アミノ酸を250mg/100g以上、イミダゾール系化合物を50mg/100g以上含む飼料を14日間以上連続して給餌すること;
ブリ属養殖魚を出荷直前に1~7日間絶食させること;及び
可食部の筋肉組織のうち、普通肉のイミダゾール系化合物の含有量が820mg/100g以上であり、前記イミダゾール系化合物中のイミダゾールジペプチドの含有率が1.0重量%以上であり、可食部の筋肉組織のうち、血合肉のタウリンの含有量が250mg/100g以上である、ブリ属養殖魚を得ること、
を含む、ブリ属養殖魚の育成方法。
(2)前記ブリ属養殖魚の体重が1.0kg以上である、(1)に記載の育成方法。
(3)前記ブリ属養殖魚の普通肉のヒスチジンの含有量が800mg/100g以上である、(1)又は(2)に記載の育成方法。
(4)前記イミダゾールジペプチドにアンセリンが含まれる、(1)~(3)のいずれかに記載の育成方法。
(5)前記飼料が、β-アラニンを1.0mg/100g以上含む、(1)~(4)のいずれかに記載の育成方法。
The present invention provides the following.
(1) A method for raising Seriola farmed fish,
Feeding Seriola farmed fish with feed containing 250 mg/100 g or more of sulfur-containing amino acids and 50 mg/100 g or more of imidazole compounds for 14 days or more continuously;
Fasting Seriola farmed fish for 1 to 7 days immediately prior to shipment; and
Of the muscle tissue of the edible part, the content of the imidazole compound in normal meat is 820 mg / 100 g or more, the content of imidazole dipeptide in the imidazole compound is 1.0% by weight or more, and the edible part obtaining a farmed Seriola fish in which the taurine content of the blood meat is 250 mg/100 g or more among the muscle tissues of
A method for raising Seriola farmed fish, comprising :
(2) The breeding method according to (1), wherein the body weight of the Seriola farmed fish is 1.0 kg or more.
(3) The breeding method according to (1) or (2), wherein the content of histidine in the normal meat of the Seriola farmed fish is 800 mg/100 g or more.
(4) The growing method according to any one of (1) to (3), wherein the imidazole dipeptide contains anserine.
( 5 ) The breeding method according to any one of (1) to (4) , wherein the feed contains 1.0 mg/100 g or more of β-alanine .
(1)可食部の筋肉組織のうち、普通肉のイミダゾール系化合物の含有量が820mg/100g以上であり、前記イミダゾール系化合物中のイミダゾールジペプチドの含有率が1.0重量%以上であり、可食部の筋肉組織のうち、血合肉のタウリンの含有量が250mg/100g以上である、ブリ属養殖魚。(1) Among the muscle tissue of the edible part, the content of the imidazole compound in normal meat is 820 mg / 100 g or more, and the imidazole dipeptide content in the imidazole compound is 1.0% by weight or more, A farmed fish of the genus Seriola, wherein the content of taurine in the blood meat is 250 mg/100 g or more in the muscle tissue of the edible part.
(2)体重が1.0kg以上である、(1)に記載のブリ属養殖魚。(2) The Seriola farmed fish according to (1), which weighs 1.0 kg or more.
(3)普通肉のヒスチジンの含有量が800mg/100g以上である、(1)又は(2)に記載のブリ属養殖魚。(3) The Seriola farmed fish according to (1) or (2), wherein the content of histidine in normal meat is 800 mg/100 g or more.
(4)前記イミダゾールジペプチドにアンセリンが含まれる、(1)~(3)のいずれかに記載のブリ属養殖魚。(4) The Seriola farmed fish according to any one of (1) to (3), wherein the imidazole dipeptide contains anserine.
(5)ブリ属養殖魚に、含硫アミノ酸を250mg/100g以上、イミダゾール系化合物を50mg/100g以上含む飼料を14日間以上連続して給餌することを含む、ブリ属養殖魚の育成方法。(5) A method for raising Seriola farmed fish, which comprises feeding Seriola farmed fish with feed containing 250 mg/100 g or more of a sulfur-containing amino acid and 50 mg/100 g or more of an imidazole compound continuously for 14 days or more.
(6)前記飼料が、β-アラニンを1.0mg/100g以上含む、(5)に記載の育成方法。(6) The breeding method according to (5), wherein the feed contains 1.0 mg/100 g or more of β-alanine.
(7)ブリ属養殖魚を出荷直前に1~7日間絶食させることを含む、(5)又は(6)に記載の育成方法。(7) The breeding method according to (5) or (6), which includes fasting the Seriola farmed fish for 1 to 7 days immediately before shipment.
Claims (7)
前記イミダゾール系化合物中のイミダゾールジペプチドの含有率が1.0重量%以上であり、
可食部の筋肉組織のうち、血合肉のタウリンの含有量が250mg/100g以上である、ブリ属養殖魚。 Among the muscle tissue of the edible part, the imidazole compound content of normal meat is 820 mg / 100 g or more,
The content of imidazole dipeptide in the imidazole compound is 1.0% by weight or more,
A farmed fish of the genus Seriola, wherein the content of taurine in the blood meat is 250 mg/100 g or more in the muscle tissue of the edible part.
The breeding method according to claim 5 or 6, comprising fasting the Seriola farmed fish for 1 to 7 days immediately before shipping.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021206642A JP7248772B1 (en) | 2021-12-21 | 2021-12-21 | Seriola farmed fish and method for raising Seriola farmed fish |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021206642A JP7248772B1 (en) | 2021-12-21 | 2021-12-21 | Seriola farmed fish and method for raising Seriola farmed fish |
Publications (2)
Publication Number | Publication Date |
---|---|
JP7248772B1 JP7248772B1 (en) | 2023-03-29 |
JP2023091832A true JP2023091832A (en) | 2023-07-03 |
Family
ID=85726024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021206642A Active JP7248772B1 (en) | 2021-12-21 | 2021-12-21 | Seriola farmed fish and method for raising Seriola farmed fish |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7248772B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004057156A (en) * | 2002-07-31 | 2004-02-26 | Itochu Shiryo Kk | Feed for pisciculture |
WO2008126781A1 (en) * | 2007-04-06 | 2008-10-23 | Kyowa Hakko Bio Co., Ltd. | Growth stimulant for fish |
JP2014150738A (en) * | 2013-02-06 | 2014-08-25 | Maruzen Pharmaceut Co Ltd | Fish feed, fish disease control agent, and fish disease control method |
JP2015151366A (en) * | 2014-02-14 | 2015-08-24 | マルハニチロ株式会社 | Raw material which inhibit visceral fat accumulation in cultured fishes, livestock and pet animals, and feed for animals using the raw material |
JP2017205045A (en) * | 2016-05-17 | 2017-11-24 | 株式会社 ヒガシマル | Method using marine heterotrophic algae, amino acid composition suitable for feed, as protein component of feed |
US20210068426A1 (en) * | 2017-11-08 | 2021-03-11 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization | Compositions and methods for aquaculturing |
-
2021
- 2021-12-21 JP JP2021206642A patent/JP7248772B1/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004057156A (en) * | 2002-07-31 | 2004-02-26 | Itochu Shiryo Kk | Feed for pisciculture |
WO2008126781A1 (en) * | 2007-04-06 | 2008-10-23 | Kyowa Hakko Bio Co., Ltd. | Growth stimulant for fish |
JP2014150738A (en) * | 2013-02-06 | 2014-08-25 | Maruzen Pharmaceut Co Ltd | Fish feed, fish disease control agent, and fish disease control method |
JP2015151366A (en) * | 2014-02-14 | 2015-08-24 | マルハニチロ株式会社 | Raw material which inhibit visceral fat accumulation in cultured fishes, livestock and pet animals, and feed for animals using the raw material |
JP2017205045A (en) * | 2016-05-17 | 2017-11-24 | 株式会社 ヒガシマル | Method using marine heterotrophic algae, amino acid composition suitable for feed, as protein component of feed |
US20210068426A1 (en) * | 2017-11-08 | 2021-03-11 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization | Compositions and methods for aquaculturing |
Also Published As
Publication number | Publication date |
---|---|
JP7248772B1 (en) | 2023-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10412937B2 (en) | Marine material derived from early developmental stages of barnacles | |
Mahé et al. | Do environmental conditions (temperature and food composition) affect otolith shape during fish early-juvenile phase? An experimental approach applied to European Seabass (Dicentrarchus labrax) | |
JP6792912B2 (en) | Raw material of compound feed, its manufacturing method, compound feed manufactured using the raw material | |
CA3072529A1 (en) | Powder made of insects, for the prevention or reduction of stress in fish being farmed | |
JP6343804B2 (en) | Preparation and breeding method of finely ground zein-embedded taurine as bivalve floating larvae feed | |
WO2002085135A1 (en) | Carotenoid-contaiing fish feeds having polyphenol added thereto | |
CA3111673A1 (en) | Method for enriching a biomass with proteins | |
JP7248772B1 (en) | Seriola farmed fish and method for raising Seriola farmed fish | |
SI22407A (en) | Application of coenzyme q10 for more effective breeding of animals and obtaining animal tissues with increased content of this coenzyme | |
JP5357830B2 (en) | Eel larvae feed | |
CA3223416A1 (en) | Isofucosterol a key nutrient for phytosterol eating animals such as pollen eating and algae-eating and plankton eating organisms | |
Abd Al-Qaisy et al. | Effect of Adding Taurine and Vitamin C on Physiological Performance and Antioxidant State of Broiler Chickens During Summer Season | |
KR101548417B1 (en) | Feed composite for culturing leptocephalus | |
BR112019008979B1 (en) | RATION AND PRODUCTION METHOD | |
JP2007236280A (en) | Method for mixed rearing of benthonic bivalve and creeping copepod | |
Osman et al. | Blood characteristics and tissue histology of Nile Tilapia (Oreochromis Niloticus Niloticus) fed a diet containing cheese skipper (Piophila casei) Larvae | |
Akbary | Growth yield, carcass traits, biochemical and non-specific immune parameters in grey mullet, Mugil cephalus Linnaeus, 1758 under cyclic starvation and L-carnitine supplementation | |
Indarsih et al. | Fresh-water Green Algae (Chlorophyta) as a Natural Pigment for Mojosari Ducks | |
Mia et al. | Studies on the haemato-biochemical changes in growing broilers after being fed on Icacina oliviformis (false yam) tuber meal | |
KR101568463B1 (en) | Liquefied feed composite for culturing leptocephalus and method for fabricating the same | |
Akinwunmi et al. | Nutritional Composition of Some Commercially Important Shrimps from Makoko Fish Landing Site, Lagos Lagoon, Nigeria | |
JP2008231070A (en) | Immuno-enhancing agent for fishes, feed composition using it, and production method of cultured fish | |
Bagno et al. | Effectiveness of extracts of medicinal plants included in poultry diet | |
Castro et al. | Dietary contribution of fermented grain pellets to the growth of juvenile Litopenaeus vannamei raised in an intensive biofloc-based rearing system | |
Sugiharto et al. | Growth and haematological response of broilers raised at high-density pens and fed germinated papaya seed and chitosan blend |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220926 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20220926 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230119 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230307 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230316 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7248772 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |